Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Jersey City › NPI 1245217751
Physician

Restivo, Carl

Restivo, Carl was paid $797K by Medicaid between Jan 2018 and Nov 2024, across 17 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 43% of everything it billed.

33Billing provider infoRESTIVO, CARL
JERSEY CITY, NJ 07307
33aNPI1245217751assigned 12/27/2005
28Total paid$797K
24GClaims33,287
24DCodes billed17
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Internal Medicine Physician providers in New Jersey

Rank by total paid#78 of 1,027
Median peer was paid$30K
This provider vs. median27×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20187,206$212K
20194,851$142K
20203,228$79K
20213,893$96K
20224,535$94K
20235,907$105K
2024incomplete3,667$70K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 43% 9,287 7,840 $346K
96401 43% 8,916 5,450 $342K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 4.3% 409 392 $34K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2.7% 2,363 1,397 $21K
20605 1.3% 446 422 $11K
99244 Office or other outpatient consultation, moderate to high complexity 1.0% 75 74 $8K
J9250 Methotrexate sodium, 5 mg <1% 8,386 5,035 $7K
73120 <1% 368 185 $7K
99245 <1% 47 47 $7K
73620 <1% 173 87 $3K
73565 <1% 138 138 $3K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 591 549 $3K
5 more codes
73030 <1% 126 $2K
20610 <1% 53 $2K
J9255 Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg <1% 739 $1K
J9260 Injection, methotrexate sodium, 50 mg <1% 38 $15.22
J0135 Injection, adalimumab, 20 mg <1% 1,132 $2.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.